Panagora Asset Management Inc Gritstone Bio, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
SELL
$1.28 - $2.85 $13,248 - $29,497
-10,350 Reduced 4.89%
201,439 $410,000
Q3 2023

Oct 31, 2023
BUY
$1.19 - $2.26 $115,180 - $218,745
96,790 Added 84.17%
211,789 $364,000
Q2 2023

Aug 11, 2023
BUY
$1.66 - $3.03 $190,898 - $348,446
114,999 New
114,999 $224,000
Q2 2022

Aug 15, 2022
SELL
$1.77 - $4.34 $27,327 - $67,005
-15,439 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$4.03 - $12.19 $17,941 - $54,269
4,452 Added 40.52%
15,439 $64,000
Q4 2021

Feb 10, 2022
SELL
$8.76 - $13.71 $720,203 - $1.13 Million
-82,215 Reduced 88.21%
10,987 $141,000
Q3 2021

Nov 10, 2021
SELL
$6.41 - $13.54 $204,363 - $431,682
-31,882 Reduced 25.49%
93,202 $1.01 Million
Q2 2021

Aug 11, 2021
BUY
$8.13 - $10.2 $930,917 - $1.17 Million
114,504 Added 1082.27%
125,084 $1.14 Million
Q1 2021

May 12, 2021
BUY
$4.07 - $27.11 $37,114 - $247,216
9,119 Added 624.16%
10,580 $100,000
Q4 2020

Feb 10, 2021
BUY
$2.57 - $4.22 $2,824 - $4,637
1,099 Added 303.59%
1,461 $6,000
Q3 2020

Nov 13, 2020
BUY
$2.63 - $8.09 $952 - $2,928
362 New
362 $1,000
Q3 2019

Nov 12, 2019
SELL
$8.45 - $12.28 $5,306 - $7,711
-628 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$9.2 - $15.7 $5,777 - $9,859
628 New
628 $7,000

Others Institutions Holding GRTS

# of Institutions
61
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email